These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 35565887)

  • 1. Role of Chrononutrition in the Antihypertensive Effects of Natural Bioactive Compounds.
    Ibarz-Blanch N; Morales D; Calvo E; Ros-Medina L; Muguerza B; Bravo FI; Suárez M
    Nutrients; 2022 May; 14(9):. PubMed ID: 35565887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks.
    Hermida RC; Ayala DE; Smolensky MH; Fernández JR; Mojón A; Portaluppi F
    Hypertens Res; 2016 May; 39(5):277-92. PubMed ID: 26657008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for the design and conduct of human clinical trials on ingestion-time differences - chronopharmacology and chronotherapy - of hypertension medications.
    Hermida RC; Smolensky MH; Balan H; Castriotta RJ; Crespo JJ; Dagan Y; El-Toukhy S; Fernández JR; FitzGerald GA; Fujimura A; Geng YJ; Hermida-Ayala RG; Machado AP; Menna-Barreto L; Mojón A; Otero A; Rudic RD; Schernhammer E; Skarke C; Steen TY; Young ME; Zhao X
    Chronobiol Int; 2021 Jan; 38(1):1-26. PubMed ID: 33342316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan.
    Kario K; Bhatt DL; Brar S; Cohen SA; Fahy M; Bakris GL
    Hypertension; 2015 Dec; 66(6):1130-7. PubMed ID: 26558819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep-time blood pressure: Unique sensitive prognostic marker of vascular risk and therapeutic target for prevention.
    Hermida RC; Ayala DE; Smolensky MH; Fernández JR; Mojón A; Portaluppi F
    Sleep Med Rev; 2017 Jun; 33():17-27. PubMed ID: 27316324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bedtime administration of long-acting antihypertensive drugs restores normal nocturnal blood pressure fall in nondippers with essential hypertension.
    Takeda A; Toda T; Fujii T; Matsui N
    Clin Exp Nephrol; 2009 Oct; 13(5):467-472. PubMed ID: 19449087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory blood pressure monitoring as an investigative tool for characterizing resistant hypertension and its rational treatment.
    White WB
    J Clin Hypertens (Greenwich); 2007 Jan; 9(1 Suppl 1):25-30. PubMed ID: 17215652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular-sleep interaction in drug-naïve patients with essential grade I hypertension.
    Grimaldi D; Provini F; Calandra-Buonaura G; Barletta G; Cecere A; Pierangeli G; Cortelli P
    Chronobiol Int; 2013 Mar; 30(1-2):31-42. PubMed ID: 23072288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
    Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
    Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure variability: clinical implications and effects of antihypertensive treatment.
    Parati G; Ravogli A; Frattola A; Groppelli A; Ulian L; Santucciu C; Mancia G
    J Hypertens Suppl; 1994 Jul; 12(5):S35-40. PubMed ID: 7965285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olmesartan medoxomil-based antihypertensive therapy evaluated by ambulatory blood pressure monitoring: efficacy in high-risk patient subgroups.
    Chrysant SG; Germino FW; Neutel JM
    Am J Cardiovasc Drugs; 2012 Dec; 12(6):375-89. PubMed ID: 23116225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes.
    Moyá A; Crespo JJ; Ayala DE; Ríos MT; Pousa L; Callejas PA; Salgado JL; Mojón A; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):116-31. PubMed ID: 23181613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypes of Hypertensive Ambulatory Blood Pressure Patterns: Design and Rationale of the ECHORN Hypertension Study.
    Spatz ES; Martinez-Brockman JL; Tessier-Sherman B; Mortazavi B; Roy B; Schwartz JI; Nazario CM; Maharaj R; Nunez M; Adams OP; Burg M; Nunez-Smith M;
    Ethn Dis; 2019; 29(4):535-544. PubMed ID: 31641320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Clinical Factors on the Achievement of Target Blood Pressure in Hypertensive Patients from Ivanovo Region of Russia: Data of 2015.
    Kiselev AR; Posnenkova OM; Belova OA; Romanchuk SV; Popova YV; Prokhorov MD; Gridnev VI
    High Blood Press Cardiovasc Prev; 2017 Dec; 24(4):425-435. PubMed ID: 28856581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morning blood pressure monitoring in the management of hypertension.
    Wang JG; Kario K; Park JB; Chen CH
    J Hypertens; 2017 Aug; 35(8):1554-1563. PubMed ID: 28379890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC; Ayala DE; Fernández JR; Mojón A
    Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambulatory Blood Pressures in Hypertensive Patients Treated With One Antihypertensive Agent: Differences Among Drug Classes and Among Drugs Belonging to the Same Class.
    de la Sierra A; Gorostidi M; Banegas JR; Segura J; Vinyoles E; de la Cruz JJ; Ruilope LM
    J Clin Hypertens (Greenwich); 2015 Nov; 17(11):857-65. PubMed ID: 26205479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.